Chilton Capital Management’s Lineage Cell Therapeutics LCTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q1
Sell
-400
Closed -$1K 432
2021
Q4
$1K Buy
+400
New +$1K ﹤0.01% 629